{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:30:23Z","timestamp":1774438223893,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jfo.2017.06.012","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T18:37:54Z","timestamp":1517510274000},"page":"170-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Uv\u00e9ites ant\u00e9rieures"],"prefix":"10.1016","volume":"41","author":[{"given":"J.","family":"Gueudry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Muraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2017.06.012_bib0335","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0340","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0345","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Gronnnup recoyymmendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch-Michel","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0350","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5301\/ejo.5000278","article-title":"Review on the worldwide epidemiology of uveitis","volume":"23","author":"Miserocchi","year":"2013","journal-title":"Eur J Ophthalmol."},{"key":"10.1016\/j.jfo.2017.06.012_bib0355","series-title":"Intraocular inflammation","first-page":"503","article-title":"Anterior uveitis","author":"Zierhut","year":"2016"},{"key":"10.1016\/j.jfo.2017.06.012_bib0360","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","article-title":"Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0039-6257(01)00231-4","article-title":"Hypopyon uveitis","volume":"46","author":"Ramsay","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0370","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0248-8663(03)00140-1","article-title":"Uv\u00e9ites chroniques s\u00e9v\u00e8res\u00a0: classification, d\u00e9marche diagnostique et principes th\u00e9rapeutiques","volume":"24","author":"Bodaghi","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jfo.2017.06.012_bib0375","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0181-5512(04)96176-1","article-title":"Les uv\u00e9ites virales","volume":"27","author":"Bodaghi","year":"2004","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0380","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bjophthalmol-2014-306474","article-title":"Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence","volume":"100","author":"Agrawal","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jfo.2017.06.012_bib0385","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ajo.2011.02.006","article-title":"QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation","volume":"152","author":"Gineys","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0390","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","article-title":"Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review","volume":"67","author":"Zeboulon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2017.06.012_bib0395","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ophtha.2016.03.010","article-title":"Description and prevalence of spondyloarthritis in patients with anterior uveitis: The SENTINEL Interdisciplinary Collaborative Project","volume":"123","author":"Juanola","year":"2016","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0400","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","article-title":"Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27\u00a0uveitis: a study of 175\u00a0cases","volume":"111","author":"Monnet","year":"2004","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0405","first-page":"1","article-title":"Clinical spectrum of HLA-B27-associated ocular inflammation","author":"Pathanapitoon","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2017.06.012_bib0410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2016.02.024","article-title":"Potential predictors of poor visual outcome in human leukocyte antigen-B27-associated uveitis","volume":"165","author":"Verhagen","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00136737","article-title":"Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossmann syndrome","volume":"11","author":"Bloch-Michel","year":"1987","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0420","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0161-6420(02)00961-2","article-title":"Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy","volume":"109","author":"Markomichelakis","year":"2002","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0425","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","article-title":"Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients","volume":"145","author":"Chee","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0430","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bjo.2005.086546","article-title":"Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis","volume":"90","author":"de Schryver","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0435","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2006.09.035","article-title":"Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients","volume":"114","author":"van Boxtel","year":"2007","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0440","first-page":"292e3","article-title":"Cytomegalovirus as an etiologic factor in corneal endotheliitis","volume":"115","author":"Koizumi","year":"2008","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0445","doi-asserted-by":"crossref","first-page":"883e1","DOI":"10.1016\/j.ajo.2008.09.001","article-title":"Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes","volume":"146","author":"Chee","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0450","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0161-6420(01)00551-6","article-title":"Is Posner Schlossman syndrome benign?","volume":"108","author":"Jap","year":"2001","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0455","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","article-title":"Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy","volume":"158","author":"Su","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0460","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12348-016-0078-z","article-title":"Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis","volume":"6","author":"Wong","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2017.06.012_bib0465","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-0420.1995.tb00661.x","article-title":"Fuchs\u2019 heterochromic iridocyclitis revisited","volume":"73","author":"Fearnley","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2017.06.012_bib0470","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00133733","article-title":"Amsler's sign associated significantly with Fuch's heterochromic cyclitis (FHC)","volume":"19","author":"Bloch-Michel","year":"1995","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0475","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0002-9394(14)72958-7","article-title":"Iris nodules in Fuchs\u2019 heterochromic uveitis","volume":"118","author":"Rothova","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0480","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.icu.0000187056.29563.8d","article-title":"Update on Fuchs\u2019 uveitis syndrome","volume":"16","author":"Mohamed","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0485","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jcrs.2006.05.010","article-title":"Cataract extraction outcomes in patients with Fuchs\u2019 heterochromic cyclitis","volume":"32","author":"Tejwani","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2017.06.012_bib0490","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jcrs.2004.08.050","article-title":"Outcomes of phacoemulsification and in-the-bag intraocular lens implantation in Fuchs\u2019 heterochromic iridocyclitis","volume":"31","author":"Javadi","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2017.06.012_bib0495","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajo.2004.02.055","article-title":"Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor","volume":"138","author":"Quentin","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0500","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00417-010-1434-6","article-title":"Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis","volume":"248","author":"Suzuki","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0505","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ajo.2008.04.011","article-title":"Rubella virus-associated uveitis: clinical manifestations and visual prognosis","volume":"146","author":"de Visser","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0510","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.05.026","article-title":"Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program","volume":"144","author":"Birnbaum","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0515","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10792-012-9649-7","article-title":"Fuchs\u2019 heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?","volume":"33","author":"Jad","year":"2013","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0520","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","article-title":"Sarcoidosis and uveitis","volume":"13","author":"Jamilloux","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jfo.2017.06.012_bib0525","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2017.06.012_bib0530","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.survophthal.2016.07.002","article-title":"The association between multiple sclerosis and uveitis","volume":"62","author":"Olsen","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0535","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0161-6420(91)32324-8","article-title":"Anterior granulomatous uveitis in patients with multiple sclerosis","volume":"98","author":"Lim","year":"1991","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0540","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jamaophthalmol.2014.3024","article-title":"Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib","volume":"132","author":"Guedj","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0545","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jfo.2015.06.002","article-title":"[Ocular manifestations of Ebola virus disease: What we learned from the last epidemic]","volume":"38","author":"Rousseau","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0550","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis?. A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2017.06.012_bib0555","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0002-9394(00)00491-8","article-title":"Anterior uveitis as a side effect of topical brimonidine","volume":"130","author":"Byles","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0560","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jfo.2012.07.002","article-title":"Pseudo-uv\u00e9ite s\u00e9v\u00e8re associ\u00e9e \u00e0 l\u2019utilisation de moxifloxacine","volume":"36","author":"Duncombe","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0565","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0929-693X(09)74053-9","article-title":"Diagnostic des uv\u00e9ites p\u00e9diatriques","volume":"16","author":"Bodaghi","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jfo.2017.06.012_bib0570","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.icu.0000177414.79030.32","article-title":"Management of chronic pediatric uveitis","volume":"16","author":"Levy-Clarke","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0575","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jfo.2010.07.002","article-title":"[Refractory anterior uveitis]","volume":"34","author":"Labalette","year":"2011","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0580","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajo.2004.09.074","article-title":"Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leukemia","volume":"139","author":"Yi","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0585","doi-asserted-by":"crossref","first-page":"RA138","DOI":"10.12659\/MSM.883260","article-title":"Ocular ischemic syndrome - a systematic review","volume":"18","author":"Terelak-Borys","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jfo.2017.06.012_bib0590","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000336676","article-title":"The gold standard of noninfectious uveitis: corticosteroids","volume":"51","author":"LeHoang","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0595","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bjo.2007.131037","article-title":"Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?","volume":"92","author":"Chang","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0600","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0161-6420(97)30065-7","article-title":"A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications","volume":"104","author":"Thach","year":"1997","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0605","first-page":"785e3","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0610","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2017.06.012_bib0615","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0620","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","article-title":"Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach","volume":"52","author":"Simonini","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jfo.2017.06.012_bib0625","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0630","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jfo.2017.06.012_bib0635","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jfo.2017.06.012_bib0640","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ICU.0b013e328010a9b5","article-title":"Update on ocular syphilis","volume":"17","author":"Gaudio","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0645","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0161-6420(99)00128-1","article-title":"The expanding clinical spectrum of ocular lyme borreliosis","volume":"107","author":"Mikkila","year":"2000","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0650","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bjophthalmol-2016-309531","article-title":"Controversies in ocular tuberculosis","volume":"101","author":"Ang","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0655","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00417-013-2535-9","article-title":"Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome","volume":"252","author":"Sobolewska","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2017.06.012_bib0660","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09273948.2016.1234625","article-title":"Biologic therapy for HLA-B27-associated ocular disorders","volume":"25","author":"Gueudry","year":"2017","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155121730476X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155121730476X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:07:40Z","timestamp":1759259260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155121730476X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S018155121730476X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2017.06.012","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uv\u00e9ites ant\u00e9rieures","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}